Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients

Background: Osteoprotegerin (OPG) belongs to the tumour necrosis factor superfamily and is known to accelerate endothelial dysfunction and vascular calcification. OPG concentrations are elevated in patients with chronic kidney disease. The aim of this study was to investigate the association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymarz, Aleksandra, Romejko, Katarzyna, Matyjek, Anna, Bartoszewicz, Zbigniew, Niemczyk, Stanisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538217/
https://www.ncbi.nlm.nih.gov/pubmed/34684610
http://dx.doi.org/10.3390/nu13103609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538217/
https://www.ncbi.nlm.nih.gov/pubmed/34684610
http://dx.doi.org/10.3390/nu13103609

Ejemplares similares